Dr. Steven B. Heymsfield joins an elite group of scholars recognized for advancing knowledge and transforming their fields. He has authored over 1,300 scientific publications with nearly 79,000 citations, placing him among the top 500 most-cited researchers globally.
The Korea University College of Medicine hosted the K-CLUB International Symposium to promote interdisciplinary collaboration and address global health challenges. Distinguished global scholars explored the future of human health from diverse perspectives, including clinical care, biomedical convergence, and health policy.
Dr. Michael J. Welsh has advanced understanding and treatment of cystic fibrosis through his pioneering research on chloride channels and CFTR function. He has developed new therapies, including a porcine model of CF, leading to improved treatments for 90% of people with the disease.
A recent study by Pennington Biomedical researchers found that pregnant women with metabolically unhealthy obesity were twice as likely to develop gestational diabetes and had more body fat at birth. Despite lower weight gain, these mothers' metabolic health played a crucial role in their baby's development.
The Pennington Biomedical Research Center has opened a new Endocrinology and Diabetes Clinic in Baton Rouge, providing specialized care for patients managing diabetes and endocrine disorders. The clinic is led by Dr. Timothy Gilbert, who brings nearly 20 years of private practice experience to the region.
Dr. Nick Burton, a researcher at Van Andel Institute, has been awarded the Pew Charitable Trusts' prestigious Pew Scholar award in Biomedical Sciences. He will investigate how environmental factors influence health, including exposure to stress and microbes, and explore new Type 2 diabetes treatments.
Researchers have discovered a way to selectively create links between sugar molecules, enabling precise control over the stereochemistry of oligosaccharides. This breakthrough could open up new avenues of biomedical research into these versatile molecules, providing access to previously difficult-to-construct oligosaccharides.
The Pew Charitable Trusts has funded 10 postdoctoral Latin American researchers for two years of biomedical science research in the US. They are exploring topics like brain tumor evolution, immune cell function, and nervous system repair.
The Pew Charitable Trusts has awarded four-year grants to 22 early-career scientists, enabling them to uncover fundamental insights about human health and disease. The selected researchers will explore various topics, including gut bacteria's role in metabolic diseases and the development of the human brain.
Answer ALS is launching a groundbreaking collaboration with Tulane University and the Pennington Biomedical Research Center to harness AI for ALS treatment discovery. The Louisiana AI Drug Development Infrastructure for ALS (LADDIA) will prioritize therapeutic targets using AI-driven insights from the Answer ALS' Neuromine Data Portal.
Researchers at Fralin Biomedical Research Institute have identified a potential target for experimental drugs that block PRMT5, a naturally occurring enzyme some tumors rely on for survival. The study found a new drug combination that works against certain hard-to-treat cancers.
Answer ALS has launched a groundbreaking collaborative initiative, LADDIA, to accelerate AI-powered drug discovery for ALS and other neurodegenerative diseases. The partnership aims to identify and prioritize therapeutic targets using AI-driven insights from the largest open-access ALS dataset.
A research team led by Virginia Tech's Fralin Biomedical Research Institute is working on a technique that uses focused ultrasound to deliver creatine directly to the brain. This method aims to restore normal brain mass in models of creatine deficiency, which can impair brain development and lead to severe cognitive challenges.
The new microscope allows researchers to map and quantify the mechanical properties of biological tissues without interfering with them, enabling real-time monitoring. This breakthrough technology has far-reaching implications for fields such as inflammation, cancer, developmental biology, and biomedical materials.
The study highlights the challenges of commercializing renewable polymers, but also emphasizes the potential of chemical modification to improve their properties for clinical use. The research aims to provide a comprehensive overview of these sustainable materials in biomedical practice.
The Greaux Healthy initiative aims to prevent and treat childhood obesity through partnerships with healthcare providers, educators, and families. The program has developed tools and resources for four priority populations, including expectant families, preschool-aged children, school-aged children, and adolescents and young adults.
The June Small Shifts campaign focuses on incorporating more fruits and vegetables into daily meals and snacks, leading to energy, mood, and immune function improvements. By making simple changes, such as adding berries or carrot sticks, individuals can make a big impact on their overall health.
The Terasaki Institute and California State University, Northridge (CSUN) have launched a new collaboration initiative that brings advanced hands-on laboratory experience to CSUN Biology graduate students. Participating students will work alongside leading scientists on projects in various fields of biomedical research.
The BIAL Foundation is now accepting nominations for the 4th edition of its international award, recognizing exceptional work in biomedical research published within the last decade. Nominations are open until June 30, with a significant increase in prize amount to €350,000.
Texas A&M University researchers have developed a customizable vessel-chip method that can mimic various blood vessel structures, enabling more accurate models of vascular disease. The chip technology enables patient-specific research and pharmaceutical testing, with the potential to cure vascular diseases.
Four researchers — Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain — are awarded the Merkin Prize for developing CAR T-cell therapy, a groundbreaking form of personalized cancer immunotherapy. The technology has led to durable remissions in tens of thousands of patients with previously incurable blood cancers.
New research from Binghamton University reveals that the topography patterns of wrinkled fingers remain constant after multiple immersions. The study found that blood vessels beneath the skin contract and move in relation to other vessels, resulting in consistent wrinkles.
Dr. Pasiakos joins Pennington Biomedical to lead research on muscle physiology, nutrition, neuroscience, and technology to optimize human performance in extreme conditions. His expertise strengthens capabilities for U.S. Military resilience, spaceflight bioenergetics, and elite athlete development.
The journal is inviting submissions on AI applications in biomedical engineering, focusing on medical device development, personalized diagnostics, and patient outcome prediction. Accepted articles will be published as part of a themed section showcasing current research on AI applications in biomedical engineering.
The American Association for the Advancement of Science (AAAS) CEO, Sudip S. Parikh, testified before the Senate Appropriations Committee about the importance of funding for biomedical research in America. He highlighted the risks of recent budget cuts and proposed budgets that could irreparably damage the nation's innovation ecosystem.
Researchers at Pennington Biomedical found that mitochondrial fragmentation can bypass defects in mitophagy to sustain skeletal muscle quality control in patients with Type 2 Diabetes. This adaptation helps maintain mitochondrial function despite impaired mitophagy.
Pennington Biomedical welcomes Dr. Adithya Hari, MD, with expertise in nuclear oncology and translational science, strengthening cancer research and patient-centered innovation in Louisiana. He will establish a research program focused on nuclear medicine and dedicate time to direct patient care through a clinical partnership.
Researchers at Pennington Biomedical Research Center investigated tirzepatide's effects on weight loss and metabolic health. The study found that tirzepatide decreased calorie intake and increased fat oxidation, leading to significant weight loss. However, the drug did not decrease the slowing down of metabolic rate usually observed wi...
Dr. Ali Khademhosseini, TIBI Director, receives the 2025 MRS Mid-Career Researcher Award for his groundbreaking contributions to biomaterials science and tissue engineering. His research has revolutionized engineered tissue constructs for drug discovery and regeneration.
The 2025 Bray Obesity Symposium provides valuable insights and guidance from leading researchers in obesity medicine. The symposium features topics such as advances in obesity genetics, pediatric obesity, lifestyle intervention, and pharmacotherapy.
Dr. Catherine Champagne, a renowned nutrition expert, has been selected as an Excellence in Nutrition Fellow by the American Society for Nutrition. She is being recognized for her outstanding contributions to the field of nutrition, including her leadership in dietary assessment and nutrition counseling.
The A*STAR Institute of Molecular and Cell Biology has achieved international recognition for research excellence while developing local scientific leaders. The institute's significant contributions include the discovery of protein kinases and phosphatases crucial to cell signalling, and the mapping of the fugu fish genome.
Dr. Leanne Redman, a leading authority on body weight regulation, has received the prestigious E.V. McCollum Award for her translational research on maternal nutrition and energy regulation, with significant impact on public health. The award recognizes her dedication to advancing research that improves women's and families' health.
The Playbook Workflow Builder simplifies data analysis and streamlines collaboration for biomedical researchers. Researchers can design custom workflows using pre-built analytical components, removing a major barrier to data-driven discovery.
Three UVA Engineering faculty members, Scott T. Acton, Gustavo Kunde Rohde and Shannon Barker, have been named to the 2025 class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. They are recognized for their contributions to biomedical engineering research, innovation, teaching and leadership.
Dr. Brian Brown is recognized for his groundbreaking work in gene therapy and functional genomics, which has helped transform the fields and contributed to key advancements in medicine and biotechnology. His innovations have been broadly used across biomedical fields, including cancer, immunology, and genetic disease research.
Researchers discovered Lepr neurons in the dorsomedial hypothalamus communicate using glutamate and GABA to regulate metabolism, body weight, and energy use. The study sheds light on fundamental neuronal interplay influencing metabolic adjustments.
A new study explores how wild animals can provide insights into novel biomedical breakthroughs. Researchers have discovered that deep-sea worms, hibernating bears, and king penguins possess unique traits that could lead to effective treatments against antibiotic-resistant infections and lifestyle diseases.
Binghamton University researchers have created a hydrogel electrode that includes conductive carbon nanotubes to monitor nerve activity in spinal cord neurons and leg muscles in mice. The technology solves the problem of rigid materials causing damage during movement, allowing for long-term functionality and single-cell signal detection.
Researchers will apply anonymized data from electronic health records to an artificial intelligence-based decision-making system to guide personalized drug dosing and treatments. The goal is enhanced blood pressure control, reduced cardiovascular risks, and improved quality of life for Type-2 diabetes patients.
The TTUHSC Graduate School of Biomedical Sciences hosted the 37th Student Research Week, showcasing student researchers' work and presentations from distinguished national speakers. The event featured an increase in abstract submissions and lightning talk sessions.
Researchers at Virginia Tech's Fralin Biomedical Research Institute found that practicing episodic future thinking reduced impulsivity and enhanced brain connectivity in key regions. The study suggests that this approach may be a valuable early intervention therapy for substance use disorders.
The review article explores multiphoton polymerization's potential in precision medicine, highlighting its noncontact, high-precision molding capabilities and diverse biomedical applications. However, challenges such as biosafety and cost issues need to be addressed for widespread adoption.
FGF21 hormone plays a key role in regulating protein appetite, making protein-rich foods more rewarding and motivating animals to seek them out. The discovery could lead to better strategies for promoting healthy eating and understanding how the body naturally regulates protein appetite.
Dr. Post's groundbreaking contributions to biomedical engineering have led to significant progress in the development of next-generation cardiovascular devices. Her leadership within the Houston innovation ecosystem underscores her dedication to fostering collaboration and driving forward medical innovation.
The article reviews additive manufacturing technology for biomedical metals, enabling customized implants with precise internal structures. It highlights the integration of AI and 4D printing, addressing challenges in production costs, regulatory compliance, and post-processing.
The Childhood Obesity Prevention, Evaluation and Treatment Toolkit provides healthcare providers with practical guidance for preventing, evaluating, and treating childhood obesity. The toolkit is grounded in scientific evidence and offers actionable treatment approaches for children and adolescents dealing with overweight and obesity.
A comprehensive review explores the evolution and application of electronic health records (EHRs) in medical research over the past 25 years. The study highlights significant advancements in data analysis, artificial intelligence, and precision medicine, while also discussing challenges such as data security and privacy.
Dr. Kaja Falkenhain, a postdoctoral researcher at Pennington Biomedical Research Center, has been awarded a postdoctoral fellowship from the American Heart Association. The fellowship will support her research project on studying brain reward circuitry and cravings in relation to obesity medication and modern food environment.
The Terasaki Institute for Biomedical Innovation has announced the recipients of its inaugural Keith Terasaki Mid-Career Innovation Award. Dr. Liangfang Zhang and Dr. Aydogan Ozcan were recognized for their innovative approaches to translating groundbreaking research into real-world impact.
The Terasaki Institute recognizes Dr. Cato Laurencin's groundbreaking contributions to regenerative engineering, while Dr. Jun Chen is recognized for his innovative technologies in soft bioelectronics and magnetoelastic materials.
A recent study introduces an innovative method for analyzing body composition, providing accurate assessments of body fat and muscle distribution. The approach utilizes deep, nonlinear methods to enhance estimation accuracy, surpassing previous linear models.
A research team led by Professor Leslie Wolf aims to increase participation in biomedical studies by empowering participants as co-researchers. The study, funded by PCORI, will investigate the impact of participant involvement on study designs and methods.
The Vilcek Foundation has awarded $250,000 in prizes to immigrant scientists recognizing their significant contributions to biomedical research. The awards include the Vilcek Prize and three Vilcek Prizes for Creative Promise, honoring scientists such as Marianne Bronner, Elham Azizi, Guosong Hong, and Maayan Levy.
The collaboration aims to develop advanced 3D mini-brain models for replicating human brain architecture, enabling researchers to explore neurological diseases and screen drug candidates. The platform offers a high-throughput screening method for rapid testing of potential drug candidates.
BioChatter bridges the gap between large language models and biomedical research by providing a transparent and adaptable framework for custom research tasks. The platform can integrate with knowledge graphs and bioinformatics tools, making it easier for researchers to analyze complex datasets.
PolyU's 16 projects funded by HMRF focus on healthcare innovation, covering areas like nursing care, health tech, and biomedical engineering. The research aims to address global healthcare challenges and improve overall well-being.
The Lancet Commission on Clinical Obesity proposes a new model for diagnosing clinical obesity based on objective measures of illness at the individual level. The proposal aims to settle the ongoing dispute around the idea of obesity as a disease, providing a medically coherent framework for diagnosis.
The Arc Institute is collaborating with NVIDIA to develop powerful computational models and tools for biomedical research. The partnership aims to advance the capabilities of the global biomedical research community through the use of generative AI.
Stephania Cormier and colleagues lead a Frontiers in Immunology research collaboration to explain RSV's complex interplay with host immune responses. The team identifies gaps in knowledge, hindering therapeutics and vaccines development.